| DNA replication |
2.16 |
0.00e+0 |
34/36 (94.44%) |
RFC5;PCNA;MCM5;...
|
| Primary immunodeficiency |
1.86 |
2.54e-2 |
33/38 (86.84%) |
IGLL1;PTPRC;ADA;...
|
| Central carbon metabolism in cancer |
1.85 |
1.70e-2 |
67/70 (95.71%) |
FGFR1;SLC2A1;SLC7A5;...
|
| Base excision repair |
1.76 |
2.70e-2 |
29/33 (87.88%) |
PCNA;PARP2;FEN1;...
|
| Pyrimidine metabolism |
1.74 |
2.80e-2 |
40/56 (71.43%) |
TYMS;DCTPP1;CANT1;...
|
| Butanoate metabolism |
1.74 |
2.44e-2 |
23/28 (82.14%) |
ALDH5A1;BDH2;HMGCS1;...
|
| One carbon pool by folate |
1.73 |
2.54e-2 |
15/20 (75%) |
TYMS;MTHFD1;ATIC;...
|
| Ribosome biogenesis in eukaryotes |
1.70 |
3.34e-2 |
52/108 (48.15%) |
RCL1;RBM28;RPP40;...
|
| Legionellosis |
-1.62 |
4.41e-2 |
51/57 (89.47%) |
HSPA6;NFKBIA;RELA;...
|
| Renal cell carcinoma |
-1.63 |
4.27e-2 |
68/69 (98.55%) |
EGLN1;MAP2K2;CDC42;...
|
| Dilated cardiomyopathy |
-1.63 |
4.38e-2 |
86/96 (89.58%) |
MYH7;CACNG4;MYH6;...
|
| Thyroid hormone synthesis |
-1.65 |
4.28e-2 |
66/75 (88%) |
GPX1;PRKCB;CREB1;...
|
| Proteasome |
-1.65 |
4.28e-2 |
44/46 (95.65%) |
PSMA2;IFNG;PSMB9;...
|
| Parathyroid hormone synthesis, secretion and action |
-1.66 |
4.00e-2 |
98/106 (92.45%) |
MMP25;PRKCB;SLC34A2;...
|
| Collecting duct acid secretion |
-1.67 |
3.93e-2 |
22/27 (81.48%) |
ATP6V1D;ATP6V1E1;ATP6V1A;...
|
| Non-alcoholic fatty liver disease |
-1.69 |
3.43e-2 |
126/155 (81.29%) |
SREBF1;RAC1;MAPK14;...
|
| Sulfur metabolism |
-1.69 |
3.33e-2 |
9/10 (90%) |
PAPSS1;TST;PAPSS2;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.71 |
2.88e-2 |
62/70 (88.57%) |
ATP6V0A4;ADAM17;RAC1;...
|
| Cortisol synthesis and secretion |
-1.71 |
2.82e-2 |
58/65 (89.23%) |
ITPR3;MC2R;CACNA1H;...
|
| Synaptic vesicle cycle |
-1.72 |
2.97e-2 |
63/78 (80.77%) |
UNC13B;SLC17A7;ATP6V1D;...
|
| Pathways of neurodegeneration |
-1.75 |
2.35e-2 |
354/475 (74.53%) |
GRIA1;ITPR3;SIGMAR1;...
|
| Protein export |
-1.75 |
2.49e-2 |
17/23 (73.91%) |
SRP9;SEC62;SEC11A;...
|
| Phagosome |
-1.76 |
2.38e-2 |
118/152 (77.63%) |
DYNC1H1;HLA-DPA1;HLA-DOB;...
|
| Pathogenic Escherichia coli infection |
-1.76 |
2.44e-2 |
152/197 (77.16%) |
CLDN9;RELA;TMBIM6;...
|
| Amyotrophic lateral sclerosis |
-1.78 |
2.11e-2 |
267/364 (73.35%) |
GRIA1;ITPR3;SIGMAR1;...
|
| Diabetic cardiomyopathy |
-1.79 |
2.06e-2 |
162/203 (79.8%) |
COX8A;G6PD;INSR;...
|
| Folate biosynthesis |
-1.81 |
2.11e-2 |
23/26 (88.46%) |
ALPL;CBR1;TH;...
|
| Prion disease |
-1.82 |
2.18e-2 |
209/273 (76.56%) |
ITPR3;RYR1;RAC1;...
|
| Protein processing in endoplasmic reticulum |
-1.85 |
1.97e-2 |
127/171 (74.27%) |
SEC61A1;CKAP4;BAG1;...
|
| Salmonella infection |
-1.95 |
6.26e-3 |
198/249 (79.52%) |
EXOC7;NAIP;ARL8B;...
|
| Thermogenesis |
-1.96 |
7.04e-3 |
173/232 (74.57%) |
MAPK14;CYC1;TSC1;...
|
| Huntington disease |
-1.99 |
6.04e-3 |
233/306 (76.14%) |
CYC1;GPX1;KIF5C;...
|
| Cardiac muscle contraction |
-2.00 |
7.04e-3 |
64/87 (73.56%) |
COX7A1;CACNB2;ATP2A1;...
|
| Parkinson disease |
-2.05 |
0.00e+0 |
176/249 (70.68%) |
PRKACA;GNAI2;MFN1;...
|
| Ribosome |
-2.05 |
0.00e+0 |
113/158 (71.52%) |
RSL24D1;MRPS12;RPS21;...
|
| Vibrio cholerae infection |
-2.14 |
0.00e+0 |
44/50 (88%) |
ERO1A;ATP6V1F;PRKCA;...
|
| Coronavirus disease |
-2.15 |
0.00e+0 |
215/232 (92.67%) |
IL2;IFNA8;RPL38;...
|
| Oxidative phosphorylation |
-2.41 |
0.00e+0 |
93/133 (69.92%) |
ATP6V1F;COX7A2L;COX6A2;...
|
